Stephen B. Howell is Director at ABEONA THERAPEUTICS INC. (ABEO). They have made 1 open-market trade across 1 company since 2019, most recently 2020-05-20.
CIK 0001464306
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $31K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABEO | 97,463 | $433K |
Shares reported on the most recent Form 4, priced at the 2020-05-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABEO | BUY | 2019-04-08 | 2019-04-10 | $7.77 | $31K | +6.5% | -0.8% | -43.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.